Ensuring Precision-Medicine Delivery for Veterans With Lung Cancer
The goal of this study is to learn if using a lay VA volunteer, who will assist patients with education regarding precision medicine, can improve care quality and outcomes for Veteran patients with lung cancer.
Checked against the public recordLast updated Feb 12, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Stanford University
- Interventions being studied
- Behavioral: Receive education on precision medicine
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * All patients 18 years old that have been newly diagnosed with any stage of lung cancer. * Patients must have the ability to understand and willingness to provide verbal consent. * Participants must speak English. Exclusion Criteria: * Inability to consent to the study, severe mental illness (e.g. schizophrenia) or institutionalization. * Patients who anticipate moving care outside the Veterans Affairs Palo Alto Health Care System within 6 months.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- VA Palo AltoPalo Alto, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 12, 2025. Always confirm current availability with the study team.